Hims & Hers Health

It's a healthcare platform that lets users talk to doctors and buy generic treatments for various sensitive and embarrassing conditions like baldness and weight. Shares soared 30% when it reported Q4 last February, then kept rising. They reported strong growth, profits and guidance. They reported another beat in May, because they were offering more products, namely weight-loss drugs, including GLP-1 injections which are in high demand. But these aren't the patented drugs from Eli Lilly and Novo Nordisk, but copycats (legal) at a much lower price. Shares jumped on this May 20 news. Then in late June a media report stated that HIMS was getting this drug from a supplier that had previously unreported, ties to fraud and bankruptcy, and that users can get these drugs without a prescription, which opens HIMS to litigation risk. Shares fell back to $20, which is an attractive level to enter. He has mixed feelings. The company was good before GLP-1 and good overall.

Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Hims & Hers Health(HIMS-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Hims & Hers Health is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Hims & Hers Health(HIMS-N) Frequently Asked Questions

What is Hims & Hers Health stock symbol?

Hims & Hers Health is a American stock, trading under the symbol HIMS-N on the New York Stock Exchange (HIMS). It is usually referred to as NYSE:HIMS or HIMS-N

Is Hims & Hers Health a buy or a sell?

In the last year, 1 stock analyst published opinions about HIMS-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Hims & Hers Health.

Is Hims & Hers Health a good investment or a top pick?

Hims & Hers Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Hims & Hers Health.

Why is Hims & Hers Health stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Hims & Hers Health worth watching?

In the last year 1 stock analyst on Stockchase covered Hims & Hers Health. The stock is worth watching.

What is Hims & Hers Health stock price?

On 2024-07-19, Hims & Hers Health (HIMS-N) stock closed at a price of $20.32.